Iron deficiency before and after bariatric surgery: The need for iron supplementation

Netherlands Journal of Medicine

Volumn 71, Issue 8, 2013, Pages 412-417

  ten Broeke, R ^a   Bravenboer, B ^b   Smulders, F J F ^a  

^a CATHARINA HOSPITAL   (Netherlands)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Anaemia; Bariatric surgery; Hepcidin; Intravenous iron supplementation; Iron deficiency

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRITIN; FERROPORTIN; FOLIC ACID; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 6; IRON; IRON SACCHARATE; PLACEBO; TRACE ELEMENT; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA;

BARIATRIC SURGERY; CONSTIPATION; DIARRHEA; DIET SUPPLEMENTATION; DRUG MEGADOSE; HOMEOSTASIS; HUMAN; HYPERFERRITINEMIA; HYPERPHOSPHATEMIA; INJECTION SITE PAIN; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; MALABSORPTION; META ANALYSIS (TOPIC); NAUSEA AND VOMITING; OBESITY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE DRUG DOSE; SKIN DISCOLORATION;

ADMINISTRATION, INTRAVENOUS; ANEMIA, IRON-DEFICIENCY; BARIATRIC SURGERY; HUMANS; IRON; TRACE ELEMENTS;

EID: 84885789572     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Daansen PF, Fogteloo AJ, Greve JW, et al. Richtlijn Morbide Obesitas. Nederlandse Vereniging voor Heelkunde. Full text: http://www.heelkunde.nl/uploads/QB/G9/QBG9ieJwBoOCR9Bwqtk6og/Microsoft-Word-richtlijn-morbide-obesitas-fnal.pdf. 2011.
2. Schigt A, Gerdes VE, Cense HA, et al. Bariatric surgery is an effective treatment for morbid obesity. Neth J Med. 2013;71:4-9.
3. Munoz M, Botella-Romero F, Gomez-Ramirez S, Campos A, Garcia-Erce JA. Iron defciency and anaemia in bariatric surgical patients: causes, diagnosis and proper management. Nutricion Hospitalaria. 2009;24:640-654.
4. Von Drygalski A, Andris DA, Nuttleman PR, Jackson S, Klein J, Wallace JR. Anemia after bariatric surgery cannot be explained by iron deficiency alone: results of a large cohort study. Surg Obes Relat Dis. 2011;7:151-156.
5. Aarts EO, van Wageningen B, Janssen IM, Berends FJ. Prevalence of Anemia and Related Defciencies in the First Year following Laparoscopic Gastric Bypass for Morbid Obesity. J Obes. 2012;2012:193705.
6. Lynch S. The rationale for selecting and standardizing iron status indicators. World Health Organization. Full text: http://www.who.int/nutrition/publications/micronutrients/background_paper3_report_assessment_vitAandIron_status.pdf. 2012
7. Evstatiev R, Gasche C. Iron sensing and signaling. Gut. 2012;61:933-952.
8. Ganz T. Molecular control of iron transport. J Am Soc Nephrol. 2007;18:394-400.
9. McClung JP, Karl JP. Iron deficiency and obesity: the contribution of inflammation and diminished iron absorption. Nutr Rev. 2009;67:100-104.
10. Anty R, Dahman M, Iannelli A, et al. Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation. Obes Surg. 2008;18:709-714.
11. Tussing-Humphreys L, Pini M, Ponemone V, Braunschweig C, Fantuzzi G. Suppressed cytokine production in whole blood cultures may be related to iron status and hepcidin and is partially corrected following weight reduction in morbidly obese pre-menopausal women. Cytokine. 2011;53:201-206.
12. Damms-Machado A, Friedrich A, et al. Pre- and postoperative nutritional deficiencies in obese patients undergoing laparoscopic sleeve gastrectomy. Obes Surg. 2012;22:881-889.
13. Love AL, Billett HH. Obesity, bariatric surgery, and iron deficiency: true, true, true and related. Am J Hematol. 2008;83:403-409.
14. Varma S, Baz W, Badine E, et al. Need for parenteral iron therapy after bariatric surgery. Surg Obes Relat Dis. 2008;4:715-719.
15. Van der Linden MW. IJzerpreparaten bij ijzergebreksanemie. Gebu. 2009;43:13-18.
16. Avgerinos DV, Llaguna OH, Seigerman M, Lefkowitz AJ, Leitman IM. Incidence and risk factors for the development of anemia following gastric bypass surgery. World J Gastroenterol. 2010;16:1867-1870.
17. Gehrer S, Kern B, Peters T, Christoffel-Courtin C, Peterli R. Fewer nutrient deficiencies after laparoscopic sleeve gastrectomy (LSG) than after laparoscopic Roux-Y-gastric bypass (LRYGB)-a prospective study. Obes Surg. 2010;20:447-453.
18. Gesquiere I, Lannoo M, Augustijns P, et al. Iron deficiency after Roux-En-Y gastric bypass: Insufficient iron absorption from oral supplements. Obes Surg. 2013 Aug 6. [Epub ahead of print]
19. Fried M, Hainer V, Basdevant A, et al. Interdisciplinary European guidelines on surgery of severe obesity. Obes Facts. 2008;1:52-59.
20. Geisser P, Rumyantsev V. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder. Arzneimittel-Forschung. 2010;60(6a):373-385.
21. Funk F, Ryle P, Canclini C, Neiser S, Geisser P. The new generation of intravenous iron: chemistry, pharmacology, and toxicology of ferric carboxymaltose. Arzneimittel-Forschung. 2010;60(6a):345-353.
22. Moore RA, Gaskell H, Rose P, Allan J. Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data. BMC Blood Dis. 2011;11:4.
23. Evstatiev R, Marteau P, Iqbal T, et al. Fergicor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology. 2011;141:846-853 e1-2.
24. PREFER studie. A single 1,000 mg dose of Ferinject rapidly improves fatigue symptoms in iron deficient, non-anaemic women (abstract). Presented at the Symposium of the "Division of General Internal Medicine". (DGIM) in Wiesbaden, 16 April 2012.